Covalent Reactions of Wortmannin under Physiological Conditions

Chemistry and Biology

Volumn 14, Issue 3, 2007, Pages 321-328

  Yuan, Hushan ^a   Barnes, Katie R ^a   Weissleder, Ralph ^a   Cantley, Lewis ^b   Josephson, Lee ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CHEMBIOL; SIGNALING

Indexed keywords

AMINO ACID; ANDROSTANE DERIVATIVE; DIMETHYL SULFOXIDE; MYCOTOXIN; SOLVENT; TETRYLAMMONIUM; WORTMANNIN;

ARTICLE; CHEMISTRY; CONFORMATION; DRUG STABILITY; KINETICS;

AMINO ACIDS; ANDROSTADIENES; DIMETHYL SULFOXIDE; DRUG STABILITY; KINETICS; MOLECULAR CONFORMATION; MYCOTOXINS; SOLVENTS; TETRAETHYLAMMONIUM;

EID: 33947218937     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2007.02.007     Document Type: Article

References (29)

1. Workman P. Inhibiting the phosphoinositide 3-kinase pathway for cancer treatment. Biochem. Soc. Trans. 32 (2004) 393-396
2. Wymann M.P., Bjorklof K., Calvez R., Finan P., Thomast M., Trifilieff A., Barbier M., Altruda F., Hirsch E., and Laffargue M. Phosphoinositide 3-kinase gamma: a key modulator in inflammation and allergy. Biochem. Soc. Trans. 31 (2003) 275-280
3. Jackson S.P., Yap C.L., and Anderson K.E. Phosphoinositide 3-kinases and the regulation of platelet function. Biochem. Soc. Trans. 32 (2004) 387-392
4. Nakanishi S., Yano H., and Matsuda Y. Novel functions of phosphatidylinositol 3-kinase in terminally differentiated cells. Cell. Signal. 7 (1995) 545-557
5. Evans J.L., Honer C.M., Womelsdorf B.E., Kaplan E.L., and Bell P.A. The effects of wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, on insulin-stimulated glucose transport, GLUT4 translocation, antilipolysis, and DNA synthesis. Cell. Signal. 7 (1995) 365-376
6. Okada T., Kawano Y., Sakakibara T., Hazeki O., and Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem. 269 (1994) 3568-3573
7. Thelen M., Wymann M.P., and Langen H. Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes. Proc. Natl. Acad. Sci. USA 91 (1994) 4960-4964
8. Wymann M.P., Bulgarelli-Leva G., Zvelebil M.J., Pirola L., Vanhaesebroeck B., Waterfield M.D., and Panayotou G. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol. Cell. Biol. 16 (1996) 1722-1733
9. Ihle N.T., Williams R., Chow S., Chew W., Berggren M.I., Paine-Murrieta G., Minion D.J., Halter R.J., Wipf P., Abraham R., et al. Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling. Mol. Cancer Ther. 3 (2004) 763-772
10. Zhu T., Gu J., Yu K., Lucas J., Cai P., Tsao R., Gong Y., Li F., Chaudhary I., Desai P., et al. Pegylated wortmannin and 17-hydroxywortmannin conjugates as phosphoinositide 3-kinase inhibitors active in human tumor xenograft models. J. Med. Chem. 49 (2006) 1373-1378
11. Knight Z.A., Gonzalez B., Feldman M.E., Zunder E.R., Goldenberg D.D., Williams O., Loewith R., Stokoe D., Balla A., Toth B., et al. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125 (2006) 733-747
12. Jackson S.P., Schoenwaelder S.M., Goncalves I., Nesbitt W.S., Yap C.L., Wright C.E., Kenche V., Anderson K.E., Dopheide S.M., Yuan Y., et al. PI 3-kinase p110β: a new target for antithrombotic therapy. Nat. Med. 11 (2005) 507-514
13. Holleran J.L., Egorin M.J., Zuhowski E.G., Parise R.A., Musser S.M., and Pan S.S. Use of high-performance liquid chromatography to characterize the rapid decomposition of wortmannin in tissue culture media. Anal. Biochem. 323 (2003) 19-25
14. Stein R.C., and Waterfield M.D. PI3-kinase inhibition: a target for drug development?. Mol. Med. Today 6 (2000) 347-358
15. Wipf P., and Halter Robert J. Chemistry and biology of wortmannin. Org. Biomol. Chem. 3 (2005) 2053-2061
16. Yuan H., Luo J., Weissleder R., Cantley L., and Josephson L. Wortmannin-C20 conjugates generate wortmannin. J. Med. Chem. 49 (2006) 740-747
17. Schultz R.M., Merriman R.L., Andis S.L., Bonjouklian R., Grindey G.B., Rutherford P.G., Gallegos A., Massey K., and Powis G. In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin. Anticancer Res. 15 (1995) 1135-1139
18. Powis G., Hill S.R., Frew T.J., and Sherrill K.W. Inhibitors of phospholipid intracellular signaling as antiproliferative agents. Med. Res. Rev. 15 (1995) 121-138
19. Creemer L.C., Kirst H.A., Vlahos C.J., and Schultz R.M. Synthesis and in vitro evaluation of new wortmannin esters: potent inhibitors of phosphatidylinositol 3-kinase. J. Med. Chem. 39 (1996) 5021-5024
20. Norman B.H., Paschal J., and Vlahos C.J. Synthetic studies on the furan ring of wortmannin. Bioorg. Med. Chem. Lett. 5 (1995) 1183-1186
21. Norman B.H., Shih C., Toth J.E., Ray J.E., Dodge J.A., Johnson D.W., Rutherford P.G., Schultz R.M., Worzalla J.F., and Vlahos C.J. Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs. J. Med. Chem. 39 (1996) 1106-1111
22. Wipf P., Minion D.J., Halter R.J., Berggren M.I., Ho C.B., Chiang G.G., Kirkpatrick L., Abraham R., and Powis G. Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin. Org. Biomol. Chem. 2 (2004) 1911-1920
23. Walker E.H., Pacold M.E., Perisic O., Stephens L., Hawkins P.T., Wymann M.P., and Williams R.L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell 6 (2000) 909-919
24. Wiesinger D., Gubler H.U., Haefliger W., and Hauser D. Antiinflammatory activity of the new mould metabolite 11-desacetoxy-wortmannin and of some of its derivatives. Experientia 30 (1974) 135-136
25. Yee M.C., Fas S.C., Stohlmeyer M.M., Wandless T.J., and Cimprich K.A. A cell-permeable, activity-based probe for protein and lipid kinases. J. Biol. Chem. 280 (2005) 29053-29059
26. Drahl C., Cravatt B.F., and Sorensen E.J. Protein-reactive natural products. Angew. Chem. Int. Ed. Engl. 44 (2005) 5788-5809
27. Schneider C.H., and De Weck A.L. A new chemical spect of penicillin allergy: the direct reaction of penicillin with epsilon-amino-groups. Nature 208 (1965) 57-59
28. Papazisis K.T., Geromichalos G.D., Dimitriadis K.A., and Kortsaris A.H. Optimization of the sulforhodamine B colorimetric assay. J. Immunol. Methods 208 (1997) 151-158
29. Gray A., Olsson H., Batty I.H., Priganica L., and Peter Downes C. Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts. Anal. Biochem. 313 (2003) 234-245